Key Takeaways from the 4th Annual NASH Roundtable™ Virtual Forum Read More »
ProSciento Becomes a California-Wide Sponsor of JDRF’s One Walks Read More »
View Recent Webinar
Community-Based Participatory Research Leads to Recruitment and Retention of NASH Subjects with Hispanic Background Read More »
A first in human, single ascending dose study to assess the safety and tolerability, pharmacokinetics, and pharmacodynamics of AB101 in subjects with type 1 diabetes Read More »
Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients. Read More »
